Literature DB >> 30191400

Molecular Targets of the Hydrophobic Block of Pluronics in Cells: a Photo Affinity Labelling Approach.

A Zhirnov1, E Nam2, G Badun1, A Romanyuk3, A Ezhov4, N Melik-Nubarov1, I Grozdova5.   

Abstract

PURPOSE: Pluronics are known as inhibitors of multidrug resistance thus making tumor cells sensitive to therapeutic doses of drugs. The purpose of our study consists in revealing molecular targets of the hydrophobic poly(propylene oxide) block of pluronics in living cells and the dependence of the polymers chemosensitizing efficiency upon targeting.
METHODS: A photo sensitive tracer was attached to the hydrophobic poly(propylene oxide) block of 3H-labeled tert-Bu-EO-PO copolymer. The conjugate was used for treatment cells in culture. We searched for its complexes with cellular lipids or proteins using RP TLC and SDS-electrophoresis, respectively. The chemosensitizing efficiency of pluronics was evaluated by their least concentrations sufficient for MDR reversion (CMDR).
RESULTS: The poly(propylene oxide) block inserts in the lipid core of plasma membrane. No preferential binding of the conjugate with any cellular protein, particularly P-gp, has been detected. FITC-labeled pluronic L61 bound to alcohol insoluble cellular targets did not participate in MDR reversion. CMDR values of 13 block copolymers have been determined. These values inversely correlated with the polymers affinity toward lipids and the ability to accelerate flip-flop.
CONCLUSION: Insertion of the hydrophobic poly(propylene oxide) block of amphiphiles in the lipid core of plasma membrane and acceleration of flip-flop of lipids underlie the mechanism of MDR reversion.

Entities:  

Keywords:  cellular membranes; lipids; multidrug resistance; polymer-biopolymer interaction; polymers

Mesh:

Substances:

Year:  2018        PMID: 30191400     DOI: 10.1007/s11095-018-2484-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

Review 1.  Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane.

Authors:  J Ferté
Journal:  Eur J Biochem       Date:  2000-01

2.  Determination of free amino groups in proteins by trinitrobenzenesulfonic acid.

Authors:  A F Habeeb
Journal:  Anal Biochem       Date:  1966-03       Impact factor: 3.365

3.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

Review 4.  Covalent Probes for Carbohydrate-Active Enzymes: From Glycosidases to Glycosyltransferases.

Authors:  Yong Xu; Najib Uddin; Gerd K Wagner
Journal:  Methods Enzymol       Date:  2017-10-31       Impact factor: 1.600

5.  Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells.

Authors:  E Batrakova; S Lee; S Li; A Venne; V Alakhov; A Kabanov
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

6.  Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization.

Authors:  E V Batrakova; S Li; S V Vinogradov; V Y Alakhov; D W Miller; A V Kabanov
Journal:  J Pharmacol Exp Ther       Date:  2001-11       Impact factor: 4.030

Review 7.  Pluronic block copolymers for overcoming drug resistance in cancer.

Authors:  Alexander V Kabanov; Elena V Batrakova; Valery Yu Alakhov
Journal:  Adv Drug Deliv Rev       Date:  2002-09-13       Impact factor: 15.470

8.  Accumulation of doxorubicin and other lipophilic amines into large unilamellar vesicles in response to transmembrane pH gradients.

Authors:  P R Harrigan; K F Wong; T E Redelmeier; J J Wheeler; P R Cullis
Journal:  Biochim Biophys Acta       Date:  1993-07-04

9.  Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers.

Authors:  Daria Yu Alakhova; Nataliya Y Rapoport; Elena V Batrakova; Alexander A Timoshin; Shu Li; David Nicholls; Valery Yu Alakhov; Alexander V Kabanov
Journal:  J Control Release       Date:  2009-10-06       Impact factor: 9.776

Review 10.  Pluronics and MDR reversal: an update.

Authors:  Daria Y Alakhova; Alexander V Kabanov
Journal:  Mol Pharm       Date:  2014-07-10       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.